Survival of men with metastatic, castration-resistant prostate cancer

Posted on December 19, 2018 by Sitemaster

There has been regular discussion here and elsewhere about the degree to which new forms of therapy have impacted patient survival since the original approval of docetaxel for treatment of metastatic, castration-resistant  prostate cancer (mCRPC). … READ MORE …

Filed under: Living with Prostate Cancer, Management, Treatment | Tagged: , , , , , | 11 Comments »

Major new cancer clinical and genetic database to be built in Boston

Posted on October 24, 2011 by Sitemaster

According to an article published today in The Boston Globe, the Dana-Farber Cancer Center and Brigham and Women’s Hospital are working together to initiate development of a very large, cancer-specific, genetic and clinical database. … READ MORE …

Filed under: Diagnosis, Management, Risk, Treatment | Tagged: , , , , , | Leave a comment »

  • Donate

  • Disclaimer

    News and information provided on this site should not be used for diagnosing or treating any health problem or disease.

    The “New” Prostate Cancer InfoLink is intended for informational purposes only. It is not engaged in rendering medical advice or professional services and is not a substitute for professional care. If you have or suspect you may have a health problem, please consult your healthcare provider.

  • Hot Posts …

  • … and Archives